Mary Ann Liebert, Inc. Aug 1 2025 A new article in the peer-reviewed journal  Nucleic Acid Therapeutics  describes the characterization of antibodies targeting antisense oligonucleotide (ASO) phosphorothioate and 2'-methoxyehtyl modifications for intracellular trafficking and biodistribution studies.  Related Stories New antibody design enhances immune system's ability to fight cancer Fusion proteins enable the creation of monoclonal antibodies Scientists use AI to build mutation-proof